NCT03684811: A Study of FT-2102 in Patients With Advanced Solid Tumors and Gliomas With an IDH1 Mutation |
|
|
| Completed | 1/2 | 93 | Europe, US, RoW | FT-2102, Azacitidine, Vidaza, Nivolumab, Opdivo, Gemcitabine and Cisplatin, Gemzar and Platinol | Forma Therapeutics, Inc. | Cohort 1a and 1b: Glioma (Advanced Gliomas and Glioblastoma Multiforme), Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas), Cohort 3a and 3b: Chondrosarcoma, Cohort 4a and 4b: Intrahepatic Cholangiocarcinoma, Cohort 5a: Other Non-Central Nervous System Solid Tumors With IDH1 Mutations | 05/21 | 06/22 | | |
